ÂÜÀòÂÒÂ×

Jinyu (Alice) Kang is a highly experienced medical professional with a robust background in clinical development and leadership roles within prominent pharmaceutical companies. Currently serving as the Global Clinical Head for Saruparib and Ceralasertib, as well as Lynparza at AstraZeneca since September 2017, Jinyu has previously held the position of VP and Head of Clinical Development at BeiGene China. Jinyu's experience at Roche included roles as Senior PD Medical Director and Associate PD Medical Director, and earlier, Jinyu contributed at Bayer Pharmaceuticals as a Scientific Relation Specialist. Jinyu began medical career as a Resident Doctor at The Central Hospital and The Second People’s Hospital. Educational qualifications include a medical degree from Sun Yat-sen University and a subsequent MD thesis in Gastroenterology and Hepatology from Duisburg-Essen University-Hospital.